Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT03492138 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Low enrollment

Conditions

Multiple Myeloma

Interventions

DRUG: ONC201
DRUG: Ixazomib
DRUG: Dexamethasone

Sponsor

Ajai Chari